What does this TikTok actually claim?
The video shows a before-and-after facial comparison while crediting GLP-1 medication for the change. Creator @alma.xoxoo uses hashtags suggesting this is part of her "wellness journey" and implies the drug caused visible facial changes.
The cryptic caption references "gl🫛-1" (GLP-1) and "Oz face," likely referring to "Ozempic face," a term that's gained traction on social media. She's positioning this as a positive transformation rather than a negative side effect.
While the video doesn't make explicit medical claims, it suggests GLP-1 medications produce noticeable facial changes that users might want to show.
Is 'Ozempic face' actually a thing?
Yes, but it's not an official medical term. Plastic surgeons report seeing patients with facial volume loss after significant weight reduction from GLP-1 medications.
The STEP 1 trial (Wilding et al., NEJM, 2021) showed 14.9% average weight loss with 2.4mg semaglutide at 68 weeks. When people lose substantial weight quickly, facial fat pads shrink, leading to a more gaunt appearance with pronounced cheekbones and hollow cheeks.
Dr. Oren Tepper, a plastic surgeon in New York, told the New York Times that patients losing 50+ pounds often develop facial hollowing. This isn't unique to GLP-1s but happens with any significant weight loss method.
The phenomenon is more pronounced with faster weight loss, which GLP-1 medications can produce compared to traditional diet and exercise alone.
What's misleading about this presentation?
The video frames facial changes as purely positive without acknowledging that many people consider "Ozempic face" undesirable. Most media coverage treats it as an unwanted side effect, not a goal.
There's also no context about the timeline or amount of weight lost. Facial volume changes typically occur with losses of 15% or more of body weight, according to facial plastic surgeons quoted in Allure magazine.
The wellness framing is problematic too. These are prescription medications for type 2 diabetes and obesity, not cosmetic treatments. The STEP trials enrolled participants with BMIs of 30 or higher, or 27+ with weight-related conditions.
What should you actually know about GLP-1 facial effects?
Facial volume loss from weight reduction isn't permanent or medically dangerous, but it can age your appearance. Some people pursue facial fillers or other cosmetic procedures to restore volume.
The effect correlates with total weight lost, not the medication itself. Someone losing 40 pounds through diet alone would likely see similar facial changes to someone losing 40 pounds on tirzepatide.
If you're considering GLP-1 medication, discuss realistic expectations with your healthcare provider. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed 22.5% weight loss with 15mg tirzepatide, which would likely produce noticeable facial changes in most people.
Remember that these medications work by slowing gastric emptying and affecting appetite-regulating hormones. Facial changes are a secondary effect of the weight loss, not a direct drug action.